Cambodia Partial Pardon for Opposition Leader May Influence Investor Sentiment Vestas Wind Systems Shares Decline After Company Flags Margins at Low End of Forecast Range Wes Streeting Proposes Capital Gains Tax Reform in Labour Leadership Bid Hormel Foods Dividend Yield Attracts Retirement Income Focus Amid Analyst Caution Apples Record High Rally Faces Key Test at June WWDC as AI Strategy Takes Center Stage MedX Holdings Announces Q1 2026 Progress MultiCity Expansion and Rebranding to Dazed Inc DAZE Beyond Air Inc XAIR Q1 2026 Earnings Narrowed Loss Slightly Exceeds Expectations as Clinical Pipeline Advances Danaos Corporation DAC Q1 2026 Earnings EPS Falls Slightly Short Amid Market Adjustments HTO Q1 2026 Earnings EPS Surpasses Estimates with 533 Beat SKIN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 421 Encompass Health Corporation EHC Q1 2026 Earnings EPS Surpasses Estimates by Nearly 6 MBC Q1 2026 Earnings Profit Beat Defies Expectations Amid Cost Discipline Legence Corp LGN Edges Higher as Stock Holds Above Key Support EDU Shows Modest Uptick Amid Sector Consolidation Support and Resistance Levels in Focus Acorn Energy Inc ACFN Pulls Back as Selling Pressure Tests Key Support Levels Syndax Pharmaceuticals SNDX Holds Steady Near 20 as Market Watches Key Levels WEX Inc WEX Edges Higher A Closer Look at the Modest Uptick and Key Technical Levels Amazon Allegedly Made Millions from NowIllegal Policy Report Claims REX Q3 2001 Earnings EPS Beats Estimates by 23 on Strong Operating Performance MoneyHero Limited MNY Dips 171 as Stock Tests Key Support Zone Braze Inc Faces Steep Decline as Technical Levels Come into Focus Valaris VAL Edges Higher as Offshore Drilling Sector Stabilizes Key Levels in Focus Takeda Pharmaceutical TAK Holds Steady at 1615 Amid Sideways Trading RiverNorth Capital and Income Fund RSF Consolidates Near 1459 as Market Awaits Catalyst Bon Natural Life Limited BON Slips 157 as It Nears Key Support at 120 Aris Mining ARIS Under Pressure Critical Support Test After 436 Decline Viridian Therapeutics VRDN Holds Steady Near Support Amid Modest Uptick